Literature DB >> 10482478

Cataract surgery in patients with Fuchs' heterochromic iridocyclitis.

K Budak1, Y A Akova, I Yalvac, D Somer, B S Aslan, S Duman.   

Abstract

PURPOSE: To evaluate the results of cataract extraction and posterior chamber intraocular lens (IOL) implantation in patients with Fuchs' heterochromic iridocyclitis (FHI).
METHODS: We studied the records of 35 patients with FHI who underwent cataract extraction. Extracapsular cataract extraction (ECCE) was performed by phacoemulsification through a scleral flap in 9 patients and by manual delivery of the nucleus through a corneal section in 26 patients.
RESULTS: After a mean follow-up time of 24 (3-60) months, the visual acuity in 21 eyes (60%) was 20/20, and all eyes had 20/40 or better vision. Six eyes with implanted regular PMMA IOL developed a marked anterior uveitis, which was resolved within 3 weeks with topical steroids. Only 1+ or 2+ cellular reaction was observed postoperatively in patients with heparin-coated lens implantation and patients who underwent phacoemulsification. Biomicroscopic evidence of giant cell activity was observed in two patients with heparin-coated IOL and in 11 with regular PMMA IOLs after ECCE (two after phacoemulsification). Four eyes developed intraocular pressure elevation that reverts to normal within 24 weeks with medical therapy.
CONCLUSIONS: These results indicate that the surgical outcomes of FHI patients after cataract surgery appear to be better when the phacoemulsification technique is used or when heparin-coated lenses are implanted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482478     DOI: 10.1016/s0021-5155(99)00020-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  5 in total

1.  Phacoemulsification and Core Vitrectomy in Fuchs' Heterochromic Uveitis.

Authors:  Sadullah Keles; Osman Ondas; Orhan Ates; Metin Ekinci; Baki Kartal; Eren Arpali; Kenan Yildirim; Erdinc Ceylan; Orhan Baykal
Journal:  Eurasian J Med       Date:  2017-06

2.  Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome?

Authors:  Bogomil Voykov; Christoph Deuter; Manfred Zierhut; Martin Alexander Leitritz; Emmanuella Guenova; Emmanuella Guenova-Hötzenecker; Deshka Doycheva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-05       Impact factor: 3.117

3.  Evaluation of radial peripapillary capillary density in patients with Fuchs uveitis syndrome.

Authors:  Yasin Sakir Goker; Pinar Cakar Ozdal; Yasemin Ozdamar Erol; Hasan Kızıltoprak; Mustafa Salih Karatepe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-22       Impact factor: 3.117

4.  Expression Profile of Intravitreous Cytokines, Chemokines and Growth Factors in Patients with Fuchs Heterochromic Iridocyclitis.

Authors:  Kaori Suzuki; Yukihiko Suzuki; Mitsuo Matsumoto; Mitsuru Nakazawa
Journal:  Case Rep Ophthalmol       Date:  2010-05-12

5.  Surgical management of secondary glaucoma in Fuchs' heterochromic iridocyclitis.

Authors:  Yi-An You; Yaming Wu; Saijing Hu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-22       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.